Purchases and Sales Made in Q3 2022 in Turning Point Therapeutics, Inc. (TPTX)
This table provides information about the institutional ownership of Turning Point Therapeutics, Inc. (TPTX) during Q3 2022. The information is specifically focused on institutions that hold shares of Turning Point Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 10, 2022
Q3 2022
|
Exodus Point Capital Management, LP
New York, NY |
SELL
|
- |
-3.05KClosed |
$0 - $232K
|
0
$0
|
|
Nov 08, 2022
Q3 2022
|
Alpha Centric Advisors LLC
San Juan, PR |
SELL
|
- |
-17KClosed |
$0 - $1.29M
|
0
$0
|
|
Nov 14, 2022
Q3 2022
|
Legal & General Group PLC
London, X0 |
SELL
|
- |
-40.9KClosed |
$0 - $3.11M
|
0
$0
|
|
Nov 14, 2022
Q3 2022
|
Farallon Capital Management LLC
San Francisco, CA |
SELL
|
- |
-1.16MClosed |
$0 - $88.2M
|
0
$0
|
|
Nov 14, 2022
Q3 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-3.79MClosed |
$0 - $288M
|
0
$0
|
|
Nov 14, 2022
Q3 2022
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-4.16MClosed |
$0 - $316M
|
0
$0
|